Published in Gene Therapy Weekly, February 15th, 2001
"When cancer cells, including melanoma cells, are genetically altered to secrete cytokines, irradiated, and injected into subjects, long-term antitumor immunity is induced," wrote L. Heller and colleagues, University of South Florida, Tampa. "Optimally, existing melanomas induced to produce cytokines in vivo could stimulate this same immune response."
Heller et al. published their study in the journal Melanoma Research ("In vivo...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.